“You will discover that every one of these individuals are over 50, however in the event you step again and take into consideration who’s now getting the AstraZeneca vaccine, it is just with just a few uncommon exceptions it is just folks over 50,” John Skerritt, head of the Therapeutic Items Administration, informed reporters. “So it’s apparent that future instances shall be within the over 50s.”
It takes the variety of confirmed instances of the uncommon clotting dysfunction in Australia to 11 for the reason that begin of the nation’s vaccine rollout. Skerritt mentioned that for each 1,000 Covid-19 vaccines administered in Australia the TGA receives between six and 7 studies of hostile reactions.
“These are individuals who have felt unwell or have offered to a physician or hospital after being vaccinated,” he mentioned.
As of Thursday afternoon there had been 2.47 million vaccine doses administered in Australia.
The federal government endorsed a brand new vaccine rollout plan in April that can fast-track vaccinations for over 50s “by higher utilising the obtainable inventory of AstraZeneca doses” and provide the Pfizer jab to folks below 50 years.